ARCHIVES

Biotherapeutics Reports LAK/IL-2 Toxicity Reduced With Constant Infusion Of IL-2

This article is from The Cancer Letter archive.

Vol. 13 No. 16 | April 17, 1987

Download PDF Visit The Full Archive

Related Articles

In Brief: Baylor Campus to Build Joint Cancer Center

January 17, 2014

House Panel Recommends $642 Million Increase For NIH; $31 Million Increase For NCI

July 21, 1995

DCPC Advisors Okay Continuation of Children’s Diet Study

January 31, 1992

Two NCI Officials Leave for Industry, Academia: Carl Barrett Goes to Novartis, Karen Antman Named Provost and Dean at Boston University.

February 18, 2005

Anti-Estrogen Drug Therapy Reduces Risk of Invasive Breast Cancer In Older Women

July 25, 2008

Melanoma Vaccine Near Phase 3, Other Studies Discussed At ACS Seminar

April 13, 1990